Impact of Brexit on marketing authorisation holders – new EMA and CMDh guidance

B

Brexiter

Active member
Messages
162,009
Reaction score
0
Points
36
The EC and EMA have published a Q&A document concerning the legal consequences for marketing authorisation holders of centrally authorised medicines if the UK becomes a ‘third country’ after Brexit.
 
You must log in or register to reply here.
Forum Community

Adminstrator Moderator Member Fanatic

Back
Top